Role of transforming growth factor-beta1/Smads in regulating vascular inflammation and atherogenesis

M W Feinberg1, M K Jain

  • 1The Program in Cardiovascular Transcriptional Biology, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. mfeinberg@rics.bwh.harvard.edu

Panminerva Medica
|February 8, 2006
PubMed

Insights

Transforming growth factor-beta1 (TGF-beta1) and its Smad mediators regulate vascular inflammation. Understanding these mechanisms offers novel therapeutic targets for chronic vascular diseases like atherosclerosis.

Area of Science:

  • Vascular Biology
  • Immunology
  • Molecular Medicine

Background:

  • Inflammation plays a key role in chronic vascular diseases including atherosclerosis.
  • Controlling inflammation presents potential therapeutic targets for vascular conditions.

Purpose of the Study:

  • To review the role of Smad mediators in regulating vascular inflammation.
  • To establish a mechanistic understanding of Smad function in chronic inflammatory vascular diseases.

Main Methods:

  • Review of existing literature on TGF-beta1 signaling and Smad proteins.
  • Analysis of Smad-mediated regulation of inflammatory processes in vascular cells.

Main Results:

  • Transforming growth factor-beta1 (TGF-beta1) exhibits potent anti-inflammatory effects.
  • Smad proteins are key downstream mediators of TGF-beta1's anti-inflammatory actions.
  • Smads regulate inflammatory cell types involved in atherosclerosis.

Conclusions:

  • Smads are crucial regulators of vascular inflammation.
  • Elucidating Smad function provides a framework for understanding cell-specific roles in vascular disease.
  • Targeting Smad pathways may offer novel therapeutic strategies for chronic vascular diseases.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...